logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David Allsup

hull york medical school
H指数:35
被引数:5,426
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Value-Based Framework for CLL Care: Results of a Scoping Review

基于价值的CLL护理框架：范围综述结果

Cancers
IF4.4
2026-10-280
OA
Stefano Molica; David Allsup
The maturation of precision medicine into pragmatic, patient-centered care: A commentary on the 2026 EHA CLL Guidelines

精准医学向务实、以患者为中心的护理模式的成熟：对2026年EHA CLL指南的评论

HemaSphere
IF14.6
2026-10-140
OAAI
Stefano Molica; Talha Munir; David Allsup
Real-world effectiveness and usage of rFIXFc prophylaxis in hemophilia B: Final results from the B-MORE study
Therapeutic Advances in Hematology
IF3.1
2026-10-080
PRE
Heidi Glosli; Mahasen Al Saleh; Beatrice Nolan; David Allsup; Susanna Ranta; Olga Benitez Hidalgo; Eva Bednar; Sabine Lauer; Stefan Lethagen;
Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014–2022: An England-wide cohort study from the UNCOVER group

2014–2022年慢性淋巴细胞白血病的趋势与社会经济差异：UNCOVER小组的英格兰全国队列研究

British Journal of Haematology
IF3.8
2026-09-060
OAAI
Temitope Erinfolami; Amelia Fisher; Indrani Karpha; Yeong Lim; Nurunnahar Akter; Toyyib Abdulkareem; Brogan Johnston; Catrin Tudur Smith; Hilary Lindsay; Shaun Bowden; Debbie Yates; Lelia Duley; Renata Walewska; Stella Williams; David Allsup; Nagesh Kalakonda; Mark Bishton; Andrew Pettitt; Nicolas Martinez-Calle
Ibrutinib versus acalabrutinib infixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy
Haematologica
IF7.9
2026-01-012
OA
Molica, Stefano; Shanafelt, Tait D.; Giannarelli, Diana; Allsu, David
A comparative documentary analysis of antifungal policies from NHS trusts participating in BioDrive Antifungal Stewardship

对参与BioDrive抗菌药物合理使用项目的NHS信托机构的抗真菌药物政策的比较文献分析

JAC-ANTIMICROBIAL RESISTANCE
IF3.3
2025-12-010
OAAI
Dar, Arzoo; Limbu, Tina; Petra, Florin-Andrei; Baz, S.; Allsup, D.; Barlow, G.; Hilton, A.
Fixed-duration BTKi-venetoclax combinations in CLL: optimizing patient-centered care
EXPERT REVIEW OF ANTICANCER THERAPY
IF2.8
2025-11-010
PRE
Molica, Stefano; Allsup, David
Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted Therapy

Pirtobrutinib在慢性淋巴细胞白血病中的应用：克服耐药性与BTK靶向疗法的个体化

Cancers 2025, Vol. 17, Page 2974
IF0
2025-09-230
OAAI
Stefano Molica; David Allsup
How should abnormal uterine bleeding be managed in people with bleeding disorders: A systematic review of the literature and thematic synthesis

异常子宫出血在出血性疾病患者中的管理：文献的系统综述与主题综合

Research and Practice in Thrombosis and Haemostasis
IF3.4
2025-09-010
OAAI
Rameen Masood; Vidiya Dev; Millie Gee; Katie Finch; Daniel M. Fletcher; Olufikayo Bamidele; Jo Traunter; David Allsup; Barbara-ann Guinn
SOHO State of the Art Updates and Next Questions | The Evolving Landscape of Prognostic Models in Chronic Lymphocytic Leukemia

SOHO 技术现状更新与后续问题 | 慢性淋巴细胞白血病预后模型的发展态势

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2025-05-140
PRE
Stefano Molica; Ahmad Ibrahim; David Allsup
Ibrutinib enhances the bias of T cell responses towards staphylococcal superantigens sustaining inflammation in chronic lymphocytic leukaemia

伊布替尼增强了T细胞应答对金黄色葡萄球菌超抗原的偏向性，这些超抗原在慢性淋巴细胞白血病中维持炎症。

FRONTIERS IN IMMUNOLOGY
IF5.9
2025-03-260
OA
Tantoush, Fisal; Allsup, David; Naylor-Adamson, Leigh; Voncken, Frank; Caserta, Stefano
PEGylation of indium phosphide quantum dots prevents quantum dot mediated platelet activation

磷化铟量子点的聚乙二醇化阻止量子点介导的血小板活化

JOURNAL OF MATERIALS CHEMISTRY B
IF5.7
2025-01-010
OAAI
Naylor-Adamson, Leigh; Price, Thomas W.; Booth, Zoe; Leonard, Sophie V. L.; Gallo, Juan; Tung, Le Duc; Harvell-Smith, Stanley; Thanh, Nguyen Thi Kim; Aslam, Zabeada; Allsup, David; Hondow, Nicole; Chamberlain, Thomas; Schneider, Jurgen E.; Naseem, Khalid; Bouillard, Jean-Sebastien G.; Stasiuk, Graeme J.; Calaminus, Simon D. J.
Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta-Analysis
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-12-060
OAAI
Molica, Stefano; Allsup, David; Giannarelli, Diana
Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis

BTK和PLCG2突变在BTK抑制剂治疗并经历疾病进展的CLL患者中的发生率：一项Meta分析

BLOOD
IF23.1
2024-11-050
PRE
Molica, Stefano; Allsup, David; Giannarelli, Diana
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-07-230
PRE
Molica, Stefano; Allsup, David; Giannarelli, Diana
Epcoritamab in B-cell malignancies: current status and prospects
EXPERT OPINION ON BIOLOGICAL THERAPY
IF4
2024-02-110
OA
Molica, Stefano; Rossi, Marco; Allsup, David
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

以可测量的残留疾病为指导的慢性淋巴细胞白血病治疗

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2024-01-2550
OA
Munir, Talha; Cairns, David A.; Bloor, Adrian; Allsup, David; Cwynarski, Kate; Pettitt, Andrew; Paneesha, Shankara; Fox, Christopher P.; Eyre, Toby A.; Forconi, Francesco; Elmusharaf, Nagah; Kennedy, Ben; Gribben, John; Pemberton, Nicholas; Sheehy, Oonagh; Preston, Gavin; Schuh, Anna; Walewska, Renata; Duley, Lelia; Howard, Dena; Hockaday, Anna; Jackson, Sharon; Greatorex, Natasha; Girvan, Sean; Bell, Sue; Brown, Julia M.; Webster, Nichola; Dalal, Surita; de Tute, Ruth; Rawstron, Andrew; Patten, Piers E. M.; Hillmen, Peter
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2023-12-154
OA
Molica, Stefano; Shanafelt, Tait D.; Allsup, David; Giannarelli, Diana
Impact of Surface Ligand on the Biocompatibility of InP/ZnS Quantum Dots with Platelets
SMALL
IF12.1
2023-11-094
OA
Gil, Helio M.; Booth, Zoe; Price, Thomas W.; Lee, Jessica; Naylor-Adamson, Leigh; Avery, Michelle; Muravitskaya, Alina; Hondow, Nicole; Allsup, David; Schneider, Jurgen E.; Naseem, Khalid; Adawi, Ali M.; Bouillard, Jean-Sebastien G.; Chamberlain, Thomas W.; Calaminus, Simon D. J.; Stasiuk, Graeme J.
Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions

针对慢性淋巴细胞白血病的TP53破坏: 当前策略和未来方向

HEMATOLOGICAL ONCOLOGY
IF3.9
2023-11-081
OA
Molica, Stefano; Tam, Constantine; Allsup, David; Polliack, Aaron

研究方向

暂未获取到该数据
R
Richard S. Houlston
H 指数:120论文数:1,250被引数:6.1万
J
James M. Allan
H 指数:56论文数:235被引数:1.1万
S
Stefano Molica
H 指数:39论文数:394被引数:5,519
A
Andrew R. Pettitt
H 指数:42论文数:251被引数:8,917
J
James R Bailey
H 指数:14论文数:25被引数:1,296
G
Graham Jackson
H 指数:70论文数:489被引数:1.7万
N
Nicola J. Sunter
H 指数:16论文数:43被引数:1,825
G
Guy Pratt
H 指数:54论文数:374被引数:1.0万
C
Chris Pepper
H 指数:50论文数:305被引数:6,966
C
Chris Fegan
H 指数:59论文数:313被引数:2.2万